Health Care & Life Sciences » Pharmaceuticals | Nichi-iko Pharmaceutical Co. Ltd.

Nichi-iko Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
7,055
9,488
15,359
5,963
9,067
8,903
Depreciation, Depletion & Amortization
6,023
4,994
5,114
7,065
8,659
9,401
Other Funds
-
-
10
4
-
1,065
Funds from Operations
11,417
14,089
14,006
7,252
21,656
19,369
Changes in Working Capital
5,871
7,090
6,909
11,328
2,731
4,442
Net Operating Cash Flow
5,546
21,179
7,097
4,076
18,925
23,811
Capital Expenditures
4,811
5,745
11,079
12,263
14,300
Sale of Fixed Assets & Businesses
16
27
-
-
-
Purchase/Sale of Investments
2,859
1,129
6,312
620
1,601
Net Investing Cash Flow
9,826
14,647
3,485
82,251
15,896
Cash Dividends Paid - Total
1,269
1,469
1,647
1,853
1,686
Issuance/Reduction of Debt, Net
9,001
12,786
12,073
80,798
4,659
Net Financing Cash Flow
20,676
14,146
10,626
70,727
3,206
Net Change in Cash
16,380
7,660
14,144
15,687
6,072
Free Cash Flow
829
17,616
736
13,321
10,565
Net Assets from Acquisitions
-
3,341
-
69,557
-
Other Sources
31
12
1,334
-
4
Change in Capital Stock
12,944
109
210
8,222
235
Exchange Rate Effect
16
46
94
87
163
Other Uses
2,203
4,471
52
1,051
-

About Nichi-iko Pharmaceutical Co.

View Profile
Address
1-6-21 Sogawa
Toyama Toyama 930
Japan
Employees -
Website http://www.nichiiko.co.jp
Updated 07/08/2019
Nichi-Iko Pharmaceutical Co., Ltd. develops, manufactures, and markets generic pharmaceutical products. Its products are classified into Prescriptive and General Over-the-Counter (OTC) drugs. These products are used for the treatment of circulatory, digestive, respiratory, central and peripheral nervous systems problems.